Deals Rumor Mill: Novartis, Air Berlin, BMW

By Benjamin Horney (October 11, 2017, 6:06 PM EDT) -- Novartis AG is opting to hold onto its 33 percent voting stake in Roche Pharma, worth about $14 billion, rather than selling it, according to a Wednesday report from Reuters. The report cited an interview with Joerg Reinhardt, chairman of Novartis, that was published in Swiss newspaper HandelsZeitung. According to the report, the company reviewed whether to divest the stake, ultimately deciding against it. Last year, Novartis CEO Joe Jimenez indicated he was willing to sell the stake, the report noted....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!